Interview with Christopher J.L. Murray, MD, DPhil, author of The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
Nancy E. Messonnier, MD is director of the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC) and leads the CDC’s efforts on COVID-19 vaccination. She joins JAMA's Q&A series to discuss the agency's response to emerging coronavirus variants, the FDA advisory hearings on the new Johnson & Johnson vaccine, and other agency activities and priorities...
Interview with James C. Robinson, PhD, author of Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic
Interview with Richard Saitz, MD, author of Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough and with Yngvild Olsen, MD, author of Overcoming Barriers to Treatment of Opioid Use Disorder
Interview with Ik-Kyung Jang, MD, PhD, author of New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes
CDC Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss the agency's response to emerging SARS-CoV-2 variants, implications for the planned vaccine mobilization strategy, the upcoming Johnson & Johnson vaccine FDA advisory hearings, strategies for reopening K-12 schools, and other agency activities and priorities related to COVID-19 control. Recorded February 17, 2021.
Related Article(s):
...Paul A. Offit, MD, of The Children's Hospital of Philadelphia returns to JAMA's Q&A series to provide an update on the emergence of COVID-19 variants and their implications for vaccine development, including the Johnson & Johnson vaccine, scheduled for a US Food and Drug Administration VRBPAC hearing on February 26, 2021. Recorded February 11, 2021.
Related Article:
As US vaccine distribution expands to include younger healthier populations, questions about vaccine safety in women of childbearing age have become more urgent. University of Texas Southwestern Medical Center's Catherine Y. Spong, MD, and Emory University School of Medicine's Denise J. Jamieson, MD, MPH, both eminent obstetrician/gynecologists, join JAMA's Q&A series to discuss the safety of the Pfizer-BioNTech and...
Interview with Lawrence O. Gostin, JD, author of Mandating COVID-19 Vaccines
Interview with Donald Berwick, MD, author of The Triple Aim Applied to Correctional Health Systems
2021 has brought news of emerging SARS-CoV-2 genetic variants that increase transmissibility. Will they diminish vaccine efficacy and lead us to lose pandemic control? University of Michigan's Adam Lauring, MD, PhD, a molecular virologist who uses evolutionary theory to study viral transmission and pathogenesis, joins JAMA's Q&A series to explain the variants and what they mean for public health. Recorded February 4, 20...
NIAID Director Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss
Related Article:
Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions
Interview with Philip A. Pizzo, MD, author of When Physicians Engage in Practices That Threaten the Nation’s Health
Interview with Peter Pronovost, MD, PhD, author of Ensuring Quality in the Era of Virtual Care and Abraham Verghese, MD, author of Virtual Care and Real Connection in the Era of COVID-19
Interview with Michael J. Barry, MD, USPSTF member and coauthor of USPSTF Recommendation: Carotid Artery Stenosis
Peter Piot, MD, PhD, director of The London School of Hygiene and Tropical Medicine, is a legend in global health, having been involved in identification of HIV and Ebola virus in Africa. He was founding executive director of UNAIDS and Under Secretary-General of the United Nations from 1995 to 2008. He joins JAMA's Q&A series to discuss the global public health response to COVID-19 past, present, and future. Recorded Janua...
Interview with Frederick P. Rivara, MD, author of Three Interventions to Address the Other Pandemic—Firearm Injury and Death
President Biden has released a health care plan that proposes reducing the age of eligibility for Medicare to 60 years and introducing a public option. Larry Levitt, MPP, Executive Vice President for Health Policy at the Kaiser Family Foundation, JAMA Associate Editor Karen Joynt Maddox, MD, MPH, Co-Director of the Center for Health Economics and Policy (CHEP) at Washington University School of Medicine, and Lawrence O. Gostin, JD,...
Interview with John P A Ioannidis, MD, DSC, author of Recalibrating the Use of Race in Medical Research
To get more vaccine to more people more efficiently, UCSF School of Medicine's Robert M. Wachter, MD, recently urged giving a single dose now and deferring the second dose until more vaccine is available. Paul A. Offit, MD, of The Children's Hospital of Philadelphia, disagrees. The two discuss the pros and the cons of the plan and alternative responses to road bumps in the US vaccine rollout, on JAMA's live Q&A seri...